Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Reindl

Showing results (11-20 of 248) with videos related to

Pageof 25
Sort By:
Journal of the Neurological Sciences|March 21, 2007
Multiple sclerosis: disease biomarkers as indicated by pathophysiologyThomas Berger, Markus Reindl
Nature Reviews. Neurology|December 19, 2018
Myelin oligodendrocyte glycoprotein antibodies in neurological diseaseMarkus Reindl, Patrick Waters
Therapeutic Advances in Neurological Disorders|October 8, 2020
Recent developments in MOG-IgG associated neurological disordersHarald Hegen, Markus Reindl
Brain : a Journal of Neurology|October 6, 2022
Inflammatory brain injury after severe viral infection is not unique to COVID-19Angelika Bauer, Markus Reindl
Disease Markers|November 25, 2006
Biomarkers in multiple sclerosis: role of antibodiesThomas Berger, Markus Reindl
Neurology(R) Neuroimmunology & Neuroinflammation|January 31, 2015
MOG antibody-associated diseasesMarkus Reindl, Kevin Rostasy
Current Opinion in Neurology|February 22, 2018
Mechanisms for lesion localization in neuromyelitis optica spectrum disordersMonika Bradl, Markus Reindl, Hans Lassmann
Physiotherapy|October 2, 2022
Factors and strategies affecting motor imagery ability in people with multiple sclerosis: a systematic reviewBarbara Seebacher, Markus Reindl, Turhan Kahraman
Journal of Neuroimmunology|August 29, 2006
Antibodies as biological markers for pathophysiological processes in MSMarkus Reindl, Michael Khalil, Thomas Berger
Expert Review of Molecular Diagnostics|March 27, 2024
Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disordersAngelika Bauer, Harald Hegen, Markus Reindl
Pageof 25

Showing results (11-20 of 248) with videos related to

Sort By:
Pageof 25
Journal of the Neurological Sciences|March 21, 2007
Multiple sclerosis: disease biomarkers as indicated by pathophysiologyThomas Berger, Markus Reindl
Nature Reviews. Neurology|December 19, 2018
Myelin oligodendrocyte glycoprotein antibodies in neurological diseaseMarkus Reindl, Patrick Waters
Therapeutic Advances in Neurological Disorders|October 8, 2020
Recent developments in MOG-IgG associated neurological disordersHarald Hegen, Markus Reindl
Brain : a Journal of Neurology|October 6, 2022
Inflammatory brain injury after severe viral infection is not unique to COVID-19Angelika Bauer, Markus Reindl
Disease Markers|November 25, 2006
Biomarkers in multiple sclerosis: role of antibodiesThomas Berger, Markus Reindl
Neurology(R) Neuroimmunology & Neuroinflammation|January 31, 2015
MOG antibody-associated diseasesMarkus Reindl, Kevin Rostasy
Current Opinion in Neurology|February 22, 2018
Mechanisms for lesion localization in neuromyelitis optica spectrum disordersMonika Bradl, Markus Reindl, Hans Lassmann
Physiotherapy|October 2, 2022
Factors and strategies affecting motor imagery ability in people with multiple sclerosis: a systematic reviewBarbara Seebacher, Markus Reindl, Turhan Kahraman
Journal of Neuroimmunology|August 29, 2006
Antibodies as biological markers for pathophysiological processes in MSMarkus Reindl, Michael Khalil, Thomas Berger
Expert Review of Molecular Diagnostics|March 27, 2024
Body fluid markers for multiple sclerosis and differential diagnosis from atypical demyelinating disordersAngelika Bauer, Harald Hegen, Markus Reindl
Pageof 25